Guidelines
Below is a list of CUA Guidelines, Best Practice Reports (BPRs), CUA-Endorsed Guidelines, and Consensus Statements.
Full-length guidelines are reserved for broader topics that require more comprehensive exploration. BPRs provide a more focused, concise summary of the best evidence available on common urological topics to help guide management decisions. Both formats have undergone official CUA guideline approval process. Where possible, the GRADE approach for summarizing the evidence and making recommendations has been used.
The CUA-endorsed guidelines have been developed by other associations and endorsed by the CUA Guidelines Committee. Note that the current ones listed have not yet been officially endorsed, as the process for such endorsement is in development.
Reproduction of any part of the published CUA guidelines, consensus statements, and best practice reports requires the express written consent of the Canadian Urological Association (CUA).
CUA GUIDELINES
- CUA/CUOG: Metastatic castration-naive and castration-sensitive prostate cancer, February 2020
- Muscle-invasive bladder cancer, August 2019
- Diagnosis, management, and surveillance of neurogenic lower urinary tract dysfunction - Executive summary, June 2019
- Diagnosis, management, and surveillance of neurogenic lower urinary tract dysfunction - Full text, June 2019
- AUA/CUA/SUFU: Recurrent uncomplicated urinary tract infections in women, May 2019
- Perioperative thromboprophylaxis and management of anticoagulation, April 2019
- 2018 update: Male lower urinary tract symptoms/benign prostatic hyperplasia (MLUTS/BPH), October 2018
- Followup of patients after treatment of non-metastatic renal cell carcinoma, August 2018
- Peyronie's disease and congenital penile curvature, May 2018
- CUA/PUC: Investigation and management of antenatally detected hydronephrosis, April 2018
- Care of the normal foreskin and neonatal circumcision in Canadian infants (full version), February 2018
- Care of the normal foreskin and neonatal circumcision in Canadian infants (abridged version), February 2018
- Recommendations on prostate cancer screening and early diagnosis, October 2017
- CUA/PUC: Diagnosis, management, and followup of cryptorchidism, July 2017
- Adult overactive bladder: Full text, May 2017
- Adult overactive bladder: Executive summary, May 2017
- Management of cystic renal lesions, March 2017
- 2016 update: Evaluation and medical management of the kidney stone patient, November 2016
- Vasectomy, August 2016
- Diagnosis and treatment of interstitial cystitis/bladder pain syndrome, May 2016
- Multicystic dysplastic kidney (MCDK) in the neonate: The role of the urologist, February 2016
- Management of ureteral calculi, December 2015
- Management of non-muscle-invasive bladder cancer, October 2015
- Workup and management of azoospermic males, August 2015
- Management of the small renal mass (SRM), June 2015
- Erectile dysfunction, February 2015
- Postoperative surveillance of upper urinary tract urothelial carcinoma, October 2013 (Update pending)
- Genetic screening for hereditary renal cell cancers, October 2013
- 2012 update: Adult urinary incontinence collaborative consensus, October 2012 (Update pending)
- Prostatitis, October 2011 (Update pending)
- Management of the incidentally discovered adrenal mass, August 2011 (Update pending)
- Prostate biopsy methodology, April 2010 (Update pending)
- Followup after radical or partial nephrectomy for localized and locally advanced renal cell carcinoma, February 2009 (Update pending)
- Management of asymptomatic microscopic hematuria in adults, February 2009 (Update pending)
CUA BEST PRACTICE REPORTS
- Holmium: YAG laser eye safety, December 2020
- Diagnosis and management of sporadic angiomyolipomas, November 2020
- Pediatric hemorrhagic cystitis, November 2019
- Diagnosis and management of radiation-induced hemorrhagic cystitis, February 2019
- Chronic scrotal pain, June 2018
CUA-ENDORSED GUIDELINES
CONSENSUS STATEMENTS
- KCRNC: The role of renal mass biopsy in the management of kidney cancer, December 2019
- KCRNC: Management of advanced kidney cancer (2019 update), October 2019
- Erectile rehabilitation following prostate cancer treatment, August 2019
- KCRNC: The role of cytoreductive nephrectomy for patients with metastatic renal cell carcinoma, June 2019
- KCRNC: The role of adjuvant therapy after nephrectomy for high-risk, non-metastatic renal cell carcinoma: A comprehensive analysis of the literature and meta-analysis of randomized controlled trials, June 2018
- CKCF: Management of advanced kidney cancer (2017 update), October 2017
- Structured assessment and followup for patients with hereditary kidney tumour syndromes, July 2016
- CUA/BCC/CUOG: Recommendations for the improvement of bladder cancer quality of care in Canada, February 2016
- CKCF: Management of advanced kidney cancer, June 2015
- CKCF: Surgical management of renal cell carcinoma, June 2014
- GAGMO: Management of carcinoma of the penis, November 2013
- CAGMO: Neoadjuvant chemotherapy should be administered to fit patients with newly diagnosed, potentially resectable muscle-invasive urothelial cancer of the bladder (MIBC), October 2013
- CAGMO: Management of small cell carcinoma of the bladder, February 2013
- 2012 update: Adult Urinary Incontinence Collaborative Consensus, October 2012
- Canadian Consensus Conference: The FDA decision on the use of 5ARIs, April 2012
- Testicular germ cell cancer, April 2010